nicolex 4 mg mundhulepulver, portionspose
fertin pharma a/s - nicotin - mundhulepulver, portionspose - 4 mg
efexor depot 37,5 mg depotkapsler, hårde
pfizer aps - venlafaxinhydrochlorid - depotkapsler, hårde - 37,5 mg
xadago
zambon spa - safinamid methansulfonat - parkinsons sygdom - anti-parkinson-lægemidler - xadago er indiceret til behandling af voksne patienter med idiopatisk parkinsons sygdom (pd) som tilføjelse terapi til en stabil dosis af levodopa (l-dopa) alene eller i kombination med andre pd lægemidler i midt-til sene svingende patienter.
hexapindol 15 mg tabletter
sandoz a/s - pindolol - tabletter - 15 mg
hexapindol 5 mg tabletter
sandoz a/s - pindolol - tabletter - 5 mg
linezolid "fresenius kabi" 2 mg/ml infusionsvæske, opløsning
fresenius kabi ab - linezolid - infusionsvæske, opløsning - 2 mg/ml
enhertu
daiichi sankyo europe gmbh - trastuzumab deruxtecan - bryst neoplasmer - antineoplastiske midler - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.
moclostad 150 mg filmovertrukne tabletter
stada arzneimittel ag - moclobemid - filmovertrukne tabletter - 150 mg
zyvoxid 2 mg/ml infusionsvæske, opløsning
pfizer aps - linezolid - infusionsvæske, opløsning - 2 mg/ml
linezolid "orion" 600 mg filmovertrukne tabletter
orion corporation - linezolid - filmovertrukne tabletter - 600 mg